baber/WOPTO huggingface dataset:
Patent AU-2010288663-B2 (AU)
Title: Velocity factor
Inventor: SCHRAEML MICHAEL
IPC: A61K39/395
Filed: 2010-08-19
Granted: 2016-02-25
Abstract: The current invention is directed to the velocity factor. Based on the velocity factor antibodies can be classified, i.e. antibodies can be characterized on their binding properties as e.g. entropic or enthalpic antigen binder. A velocity factor based classification does not require detailed thermodynamic determinations and/or calculations. The velocity factor is the ratio of the antigen-antibody complex association rate constants ka determined at 37 °C and 13 °C. As only two experimental determinations are required to calculate the velocity factor this is a fast and high-throughput suited method.
Patent AU-2010337438-B2 (AU)
Title: Sample processing cartridge and method of processing and/or analysing a sample under centrifugal force
Inventor: BORCH STIG MORTEN
IPC: B01L3/00
Filed: 2010-12-28
Granted: 2014-09-25
Abstract: The present invention relates to a sample processing cartridge (10) for carrying out processing under centrifugal force acting in at least two directions as the orientation of cartridge relative to centrifugal force is changed, the cartridge comprising: a first cavity (18) adapted to contain a sample; and a second cavity (22) in fluid communication with the first cavity, wherein the first and second cavities are arranged such that the sample in the first cavity is moved therefrom to the second cavity as a centrifugal force acting on the cartridge is changed from a first direction (30) to a second direction (36), the first cavity is elongated perpendicular to the centrifugal force acting in the first direction, and the second cavity is more shallow than the first cavity and more extended in the direction of the centrifugal force acting in the second direction than the first cavity is extended in the direction of the centrifugal force acting in the first direction.. The present invention also relates to a method of processing and/or analysing a sample under centrifugal force.
Patent AU-2010360603-B2 (AU)
Title: Digital input with variable impedance
Inventor: BJORKLUND HANS
IPC: G01R31/317
Filed: 2010-09-16
Granted: 2014-07-03
Abstract: A device (400) for sensing a binary signal (450) is provided. The device comprises means (410) for measuring a signal level of the signal, means (420) for determining whether the measured signal level is "low" or "high", means (430) for providing a variable input impedance, and means (440) for controlling the input impedance in response to the measured signal level. The variable input impedance may be provided by way of a transistor (T) and a resistor (R), and by controlling the duty ratio of the transistor using pulse width modulation. Preferably, the input impedance is controlled to be low for low signal levels and to be high for high signal levels, which results in a more reliable sensing of binary signals. The device may be used for detecting the state of contact transducers suffering from parasitic resistances caused by moist and/or polluted environments. Further, a method of sensing a binary signal is provided.
Patent AU-2011201303-B2 (AU)
Title: Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
Inventor: SENYEI ANDREW
IPC: C12Q1/68
Filed: 2011-03-22
Granted: 2012-07-26
Abstract: ONCOFETAL FIBRONECTIN AS A MARKER FOR DISEASE AND OTHER CONDITIONS AND METHODS FOR DETECTION OF ONCOFETAL FIBRONECTIN 5 Abstract Methods and products for the detection of oncofetal fibronoctin indicating molocules in samples are provided. Methods for imaging of oncofetal fibronectin are provided. In some methods provided herein, the sample is treated with a reagent and/r contacted with a 10 non-specific binder. Provided are methods for testing subjects to ascertain health and disease status and to assess the risk of developing a disease or condition. Methods for detecting the presence of oncofetal fibronectin indicating molecules by a variety of methods such as immunossays and mass spectrometry also are provided. Methods and products for detection of oncofetal fibronectin for selection of concepti are provided.
Patent AU-2011202536-B2 (AU)
Title: Method of performing anterior cruciate ligament reconstruction using biodegradable interference screw
Inventor: WHITTAKER GREGORY
IPC: A61B17/58
Filed: 2011-05-31
Granted: 2012-04-05
Abstract: - 18 Abstract A method of replacing an ACL with a graft. The method provides for the 5 drilling bone tunnels in a femur and a tibia. A replacement graft is provided having first and second ends. A biodegradable composite screw is provided. The screw is made from a biodegradable polymer and a bioceramic or a bioglass. At least one end of the graft is secured in a bone tunnel using the biodegradable composite screw. 17/05/11,19250 speci.doc,18 FIG. lB
Patent AU-2011202890-B2 (AU)
Title: Heavy-load radial tyre
Inventor: YAMAHIRA ATSUSHI
IPC: B60C11/00
Filed: 2011-06-16
Granted: 2014-07-24
Abstract: HEAVY-LOAD RADIAL TYRE A heavy-load radial tyre (1) comprises a tread portion (2), wherein in a tyre meridian section including a tyre axis under a normally inflated unloaded condition in which the tyre (1) is mounted on a standard wheel rim and inflate to a standard pressure but loaded with no tyre load, the tread portion (2) comprises a crown portion (TC) and a pair of shoulder portions (TS) each disposed axially outside the crown portion (TC) and including a tread edge (Te), the crown portion (TC) has a crown profile (12A) being a circular arc of a radius of curvature (TRI) of which the center is on a tyre equatorial plane (Co), the shoulder portion (TS) has a shoulder profile (12B) being a circular arc of a radius of curvature (TR2) which crosses the crown profile (12A) at an intersection point (P) so that a tangent line (Y) on the shoulder profile (12B) at the intersection point (P) inclines at angle of not more than 7 degrees with respect to a tyre axial direction, wherein the radius of curvature (TR2) is 0.60 to 0.95 times the radius of curvature (TR1), a plurality of sipes (15) are provided in the shoulder portion (TS), and each sipe (10) extends from the tread edge (Te) toward the tyre equatorial plane without going beyond the shoulder portion (TS). G(Gc) TC(12A) TS(12B) 2 11 0 G(G Te 7 83Sb C o 6(6A)
Patent AU-2011226695-B2 (AU)
Title: Scaffold system to repair cardiovascular conditions
Inventor: KAUFMANN J JORDAN MASSEY
IPC: A61M29/02
Filed: 2011-03-11
Granted: 2015-07-09
Abstract: A device for treating a cardiovascular condition includes an expandable scaffold positionable in a portion of a vasculature of a mammal; and maintained via stent technology, wherein the scaffold is comprised of electrospun fibers composed of a biodegradable compound. The biodegradable compound serves as a temporary template that allows the cardiovascular tissue to be rebuilt about the scaffold.
Patent AU-2011233563-B2 (AU)
Title: Lightweight heat sinks and LED lamps employing same
Inventor: CHOWDHURY ASHFAQUL I
IPC: F21K99/00
Filed: 2011-03-18
Granted: 2015-09-24
Abstract: A heat sink (10) includes a thermally conductive layer (14) comprising at least one of fullerenes and nanotubes disposed in a polymeric host. The thermally conductive layer may be disposed on a heat sink body, which may be thermally insulating and/or plastic, and may include surface area enhancing heat radiating structures, such as fins (16), with the thermally conductive layer being disposed over at least the surface area enhancing heat radiating structures. A light emitting diode (LED) -based lamp embodiment includes the heat sink and an LED module (30) including one or more LED devices (32) secured with and in thermal communication with the heat sink. A method embodiment includes forming the heat sink body and disposing the thermally conductive layer on the heat sink body. The disposing may comprise spray coating. An external energy field may be applied during spray coating to impart a non -random orientation to nanotubes in the polymeric host.
Patent AU-2011242825-B2 (AU)
Title: Alias management and value transfer claim processing
Inventor: RAJ ASHWIN
IPC: G06Q20/38
Filed: 2011-04-19
Granted: 2015-01-22
Abstract: An alias management and value transfer claim processing system is disclosed. A sending entity initiates value transfer identifying a recipient entity using an alias that is unregistered with the system. The value transfer is authorized, but not settled until the recipient entity registers with the system and claims the value transfer. The registered alias can be used for subsequent value transfers.
Patent AU-2011254528-B2 (AU)
Title: Ergonomic dispenser interface
Inventor: CAHEN ANTOINE
IPC: H01H25/06
Filed: 2011-05-20
Granted: 2015-04-23
Abstract: A machine (1) for preparing a beverage has: a beverage preparation module for processing one or more beverage ingredients and for dispensing a beverage resulting therefrom; a unit for controlling such processing in accordance with a parameter set to a value stored in the unit; and a user-interface (20) connected to the control unit for acquiring the value from a user and storing the value in the control unit. The user-interface has a first user-selector (21) associated with a first value for the parameter and a second user-selector (22) associated with a second value for the parameter. The first and second user-selectors (21, 22) each comprises a user-actuation adjustment direction (211, 221) for shifting on user-actuation in the adjustment direction the value associated with the user-selector to a user-selected adjusted value selected from a range of values associated with the user-selector. Furthermore, each of the user-selectors comprises a user-actuation initiation direction (212, 222) for initiating on user-actuation in the initiation direction: the control unit to store the user-selected adjusted value as the stored value; and/or the processing in accordance with the parameter set to the user-selected adjusted value as said stored value.
Patent AU-2011261669-B2 (AU)
Title: Magnetically coupled implantable pump system
Inventor: AUGARTEN MIKE
IPC: A61F5/00
Filed: 2011-05-27
Granted: 2015-12-10
Abstract: A magnetically coupled, implantable pump system comprises an external controller and an implantable device. A non-implantable magnet in an external controller produces a magnetic field that couples the non-implantable magnet to a magnet in the implantable device. A non-implantable motor moves the non-implantable magnet in a rotational direction. When the non-implantable magnet moves in the rotational direction, a piston coupled to the magnet moves within the implantable device. As the piston moves, an amount of fluid from a reservoir in the implantable device moves out of the reservoir and into an inflatable portion of a gastric band. The implantable device may also move fluid out of the inflatable portion of the gastric band.
Patent AU-2011268754-B2 (AU)
Title: Magnetron power supply
Inventor: LIDSTROM KJELL
IPC: H05B6/68
Filed: 2011-06-17
Granted: 2014-11-06
Abstract: A power supply for a magnetron has a high voltage converter (101), a microprocessor (103) and a resistor (109). The high voltage converter comprises an integrated circuit oscillator IC1, switching transistors T1,T2, an inductance LI, a transformer (106) and a rectifier (107). A voltage source (4) supplies an augmented DC voltage to the converter (101). An operational amplifier (122), arranged as an error signal magnifier with an integrating capacitor C7 and a resistor R9, compares a control signal from microprocessor (103) and resistor (109) and supplies an output signal to the oscillator IC1. Oscillator IC1 controls switching transistors T1,T2, the output of which connect to inductance LI and the primary winding of the transformer (106). The secondary winding of the transformer (106) is connected to half bridge diodes D3, D4, D5, D6 and capacitors C5, C6 which provide DC current from the transformer to the magnetron (102).
Patent AU-2011276158-B2 (AU)
Title: Cancer therapy using CLDN6 target-directed antibodies in vivo
Inventor: SAHIN UGUR
IPC: C07K16/28
Filed: 2011-07-04
Granted: 2016-02-25
Abstract: The invention relates to the treatment and/or prevention of tumor diseases associated with cells expressing CLDN6, in particular cancer and cancer metastasis using antibodies which bind to CLDN6. The present application demonstrates that the binding of antibodies to CLDN6 on the surface of tumor cells is sufficient to inhibit growth of the tumor and to prolong survival and extend the lifespan of tumor patients. Furthermore, binding of antibodies to CLDN6 is efficient in inhibiting growth of CLDN6 positive germ cell tumors such as teratocarcinomas or embryonal carcinomas, in particular germ cell tumors of the testis.
Patent AU-2011295398-B2 (AU)
Title: Composition and method of manufacture
Inventor: PIRAEE MAHMOOD
IPC: A23L33/15
Filed: 2011-08-25
Granted: 2016-03-31
Abstract: A dietary supplement composition comprises a synergistic combination of saffron and resveratrol for providing anti-oxidant and gene modulation effects for preventing, ameliorating and/or reducing a rate of development and progression of age-related macular degeneration (AMD). Optionally, the combination is supplemented with one or more further ingredients: fish oil, Zinc, Copper, vitamin C, vitamin E, lutein, zeaxanthin. The combination is beneficially provided as a composition which is useful for reducing a risk of developing, and/or for reducing a rate of progression of age-related macular degeneration, and/or for preventing age-related sight loss, and other age-related diseases.
Patent AU-2011299353-B2 (AU)
Title: Treatment of diseases
Inventor: BAR-OR DAVID
IPC: A61P27/02
Filed: 2011-09-07
Granted: 2016-02-25
Abstract: The invention provides a method of inhibiting vascular hyperpermeability in an animal in need thereof. The method comprises administering an effective amount of a diketopiperazme, a prodrug of a diketopiperazme or a pharmaceutically-acceptable salt of either of them to the animal, wherein the diketopiperazme has the formula set forth in the specification. The invention also provides a method of modulating the cytoskeleton of an endothelial cell in an animal. The method comprises administering an effective amount of a diketopiperazme, a prodrug of a diketopiperazme or a pharmaceutically-acceptable salt of either of them to the animal, wherein the diketopiperazme has the formula set forth in the specification. The invention further provides a kit. The kit comprises a diketopiperazme, a prodrug of a diketopiperazme or a pharmaceutically-acceptable salt of either of them to the animal, wherein the diketopiperazme has the formula set forth in the specification.
Patent AU-2011316667-B2 (AU)
Title: Dry weight predictor
Inventor: LEVIN NATHAN W
IPC: G06F19/10
Filed: 2011-10-12
Granted: 2015-01-22
Abstract: Methods and apparatus for predicting/estimating the dry weight of an individual, e.g., a patient undergoing dialysis treatment, are provided. The techniques employ a bioimpedance measurement (303) on the individual's calf (101) to obtain information regarding the extracellular fluid volume of the calf. Using a measurement of the calf's circumference (309), a resistivity value is calculated, normalized by the individual's body mass index (BMI), and then offset by a reference value to obtain a new variable, ΔnRho, which is shown, by comparison with a "gold standard" (FIGS. 5-9), to be highly effective in predicting/estimating dry weight (FIGS. 10-13 and 15-16). The techniques are easy to use and provide accurate dry weight predictions/estimations without substantially adding to the complexity or cost of dialysis procedures. The techniques can also be used for individuals who are not renal patients, e.g., patients suffering from other diseases in which fluid overload can occur, athletes, fitness enthusiasts, and the like.
Patent AU-2011323164-B2 (AU)
Title: Crystalline forms of hydrochloride salt of (4a-R,9a-S) -1- (1h - benzoimidazole- 5 -carbonyl) -2, 3, 4, 4a, 9, 9a - hexahydro -1h- indeno [2, 1 -b] pyridine- 6 -carbonitrile and their use as HSD 1 inhibitors
Inventor: ECKHARDT MATTHIAS
IPC: C07D401/06
Filed: 2011-11-04
Granted: 2015-07-23
Abstract: The present invention relates to crystalline compounds of the following structural formula (II) possessing valuable pharmacological activity. Particularly, the compounds are inhibitors of 11 β-hydroxysteroid dehydrogenase (HSD) 1 and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this enzyme, such as metabolic diseases, in particular diabetes type 2, obesity, and dyslipidemia.
Patent AU-2011332851-B2 (AU)
Title: Heat sealer with algorithm for regulating sealing temperature
Inventor: LIU ZHU
IPC: B65B51/14
Filed: 2011-11-23
Granted: 2015-09-24
Abstract: A vacuum and sealing appliance comprises a heat sealing element for sealing a container during a sealing cycle. A controller controls the temperature of the heat sealing element during the sealing cycle based on a signal from a temperature sensor that senses the real-time temperature of the heat sealing element. A seal indicator light is provided which is lighted during the sealing cycle and extinguished at its completion. The signal from the controller energizes the heating element for a time to heat the sealing element to a pre-determined temperature for sealing the container and initiates a dwell time corresponding to cooling the heating element after sealing the container. Values of the real -time temperatures of the heat sealing element and values of the sealing times and the dwell times that correspond to the values of the real-time temperatures of the heat sealing element are stored in a look-up table.
Patent AU-2011375735-B2 (AU)
Title: Fabric wrinkle reduction composition
Inventor: PESCADOR JOSE JAVIER TOVAR
IPC: C11D3/37
Filed: 2011-09-15
Granted: 2014-07-31
Abstract: A fabric conditioner composition comprising: a cationic fabric softener, and 0.02 to 0.32% by weight of an amino-functional, epoxide group containing silicone polymer having a weight average molecular weight of 400,000 to 900,000. Also, a method of reducing wrinkles on fabric during laundering comprising laundering the fabric with a composition comprising 0.02 to 0.32% by weight of an amino-functional, epoxide group containing silicone polymer having a weight average molecular weight of 400,000 to 900,000. The polymer is unexpectedly effective at low levels of use.
Patent AU-2012203234-B2 (AU)
Title: Heliostat control
Inventor: BURTON ALEXANDER IAN
IPC: F24S50/20
Filed: 2011-12-22
Granted: 2012-09-06
Abstract: Abstract Solar energy collection apparatus comprises a solar energy receiver defining a primary target to receive directed sunlight. A field of heliostats is mounted for angular adjustment to optimally receive a beam of sunlight and direct it to the primary target of 5 the solar energy receiver. Each heliostat includes low precision sensors for determining the angular position of the respective heliostat mirror. Actuator means is provided to effect said angular adjustment of each heliostat of the field. A secondary target at or spaced from said primary target is disposed so as not to be intercepted by said optimally received and directed beams of sunlight. A controller operably coupled to said 0 actuator means is configured to sequentially cause, during operation of the solar energy collection apparatus, a temporary angular adjustment of the respective said heliostats so as to divert the beam of sunlight received at each heliostat to said secondary target for a predetermined period of time. Recordal means is provided to record a representation of each diverted beam at the secondary target. The controller is also 5 coupled to the recordal means and is further configured to respond to the representation of the diverted beam for the respective heliostats when a parameter or element thereof deviates from a reference norm, by activating the actuator means to angularly adjust the corresponding heliostat to improve the accuracy of its receipt of said beam of sunlight and direction of the beam to the primary target, thereby compensating by closed loop 0 control of the field of heliostats during operation of the apparatus for tolerances in heliostat and actuator geometries.
Patent AU-2012213258-B2 (AU)
Title: Fuel cells
Inventor: SUTHERLAND HUGH LIAM
IPC: H01M4/90
Filed: 2012-01-18
Granted: 2016-11-03
Abstract: A liquid electrolyte fuel cell comprises means to define an electrolyte chamber (208), and two electrodes (10), one on either side of the electrolyte chamber (208), each electrode comprising: - a sheet (11) of metal through which are defined a multiplicity of through-holes (14), and - a gas-permeable layer (16) of fibrous and/or particulate electrically-conductive material which is bonded to and in electrical contact with the sheet of metal (11), and which comprises catalytic material (18). The electrode (10) may be arranged such that the gas-permeable layer (16) faces the electrolyte chamber (208).
Patent AU-2012235792-B2 (AU)
Title: Method of manufacturing absorbent articles having a waistband
Inventor: SCHLINZ DANIEL R
IPC: A61F13/49
Filed: 2012-02-21
Granted: 2016-01-14
Abstract: A method of manufacturing an absorbent article includes directing a web of side panel material and a waist elastic material separate from the web of side panel material to travel. The waist elastic material is bonded to the web of side panel material. The web of side panel material having the waist elastic material bonded thereto is cut to form a side panel having a waistband portion. The side panel having the waistband portion is attached to a chassis.
Patent AU-2012244302-B2 (AU)
Title: A method for treating or preventing either one or both of an inflammatory disease and an autoimmune disease
Inventor: BUCKEL PETER
IPC: A61P37/02
Filed: 2012-10-31
Granted: 2014-08-21
Abstract: The present invention relates to a method for treating or preventing either one or both of an inflammatory disease and an autoimmune disease in a patient, wherein the method comprises providing a pharmaceutical composition containing a therapeutically effective amount of soluble FcyR; administering said composition to a patient, followed by a safety period of several weeks, followed by a subsequent treatment cycle of at least two weekly administrations, wherein said therapeutically effective amount is effective to treat or prevent said disease in said patient. Further to a pharmaceutical composition in the form of a multiple-dosage-kit which contains sufficient amounts of administration doses of soluble FcyR for effectively treating or preventing inflammatory diseases and/or autoimmune diseases in a patient.
Patent AU-2012247029-B2 (AU)
Title: Multivalent Avian Influenza vaccines
Inventor: PLANA-DURAN JUAN
IPC: A61K39/145
Filed: 2012-11-07
Granted: 2017-02-02
Abstract: CANRPorbl\DCOAMC\73722_1.DOC-14I/09/20I A vaccine composition and method which is effective in preventing or ameliorating Avian Influenza Virus infection is set forth herein. The vaccine contains at least two 5 inactivated strains of avian influenza virus, wherein the combined haemoagglutinin (HA) total is at least about 200 HA/dose of the vaccine composition, and wherein each of the strains presents at least about 128 HA/dose, and further wherein one of the strains has the same HA subtype as that of a challenge virus, and wherein at least one of the strains has a different NA subtype than the challenge virus.